Lv5
1430 积分 2024-03-09 加入
Cell Wall-Binding Proteins-Armed Controlled-Release Nanodelivery System Enhances Nisin’s Efficacy against Streptococcus pneumoniae Infections
1天前
已完结
Abstract 3622: Precision therapy against CRC associated Fusobacterium nucleatum using bioengineered probiotics expressing guided antimicrobial peptides (gAMPs)
1天前
已关闭
Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment
1个月前
已完结
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
1个月前
已完结
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
1个月前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
1个月前
已完结
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
1个月前
已完结
FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond
1个月前
已完结
皖公网安备34019202002308